CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
EnglishLAROCCA, Alessandra
Risultati 1 - 20 di 76 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 31 | Treatment of newly diagnosed multiple myeloma. | 2008 | Palumbo A;Magarotto V;Larocca A;Bringhen S;Falco P;Di Raimondo F;Baldini L;Boccadoro M |
| 32 | Treatment of newly diagnosed elderly multiple myeloma | 2016 | Fouquet, Guillemette; Gay, Francesca; Boyle, Eileen; Bringhen, Sara; Larocca, Alessandra; Facon, Thierry; Leleu, Xavier; Palumbo, Antonio |
| 33 | Treatment of newly diagnosed elderly multiple myeloma | 2016 | Fouquet, Guillemette; Gay, Francesca; Boyle, Eileen; Bringhen, Sara; Larocca, Alessandra; Facon, Thierry; Leleu, Xavier; Palumbo, Antonio |
| 34 | THROMBOPROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLEMYELOMA PATIENTS TREATED WITH LENALIDOMIDE-BASEDREGIMENS: A RANDOMIZED PHASE III STUDY OF ASPIRINVS ENOXAPARIN | 2011 | A Larocca; F Cavallo; A Evangelista; F Di Raimondo; L Catalano; M Galli; C Cangialosi; G Benevolo; D Rossi; T Guglielmelli; L Masini;F Rossi; R Ria; N Cascavilla; N Pescosta;A Baraldi; M Marcatti; T Caravita Di Toritto;A Nagler;M Boccadoro; A Palumbo |
| 35 | The impact of response on bone-directed therapy in patients with multiple myeloma. | 2013 | Larocca A;Child JA;Cook G;Jackson GH;Russell N;Szubert A;Gregory WM;Brioli A;Owen RG;Drayson MT;Wu P;Palumbo A;Boccadoro M;Davies FE;Morgan GJ |
| 36 | The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens | 2011 | Benevolo G; Larocca A; Gentile M; Pregno P; Gay F; Botto B; Frairia C; Evangelista A; Morabito F; Boccadoro M; Vitolo U; Palumbo A. |
| 37 | Special problems in the management of elderly patients with multiple myeloma | 2018 | Gay, Francesca*; Larocca, Alessandra |
| 38 | A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients | 2013 | Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A |
| 39 | Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. | 2014 | Palumbo A;Bringhen S;Kumar SK;Lupparelli G;Usmani S;Waage A;Larocca A;van der Holt B;Musto P;Offidani M;Petrucci MT;Evangelista A;Zweegman S;Nooka AK;Spencer A;Dimopoulos MA;Hajek R;Cavo M;Richardson P;Lonial S;Ciccone G;Boccadoro M;Anderson K;Barlogie B;Sonneveld P;McCarthy PL |
| 40 | Second primary malignancies in multiple myeloma: an overview and IMWG consensus | 2016 | Musto, P; Anderson, K C; Attal, M; Richardson, P G; Badros, A; Hou, J; Comenzo, R; Du, J; Durie, B G M; Miguel, J San; Einsele, H; Chen, W M; Garderet, L; Pietrantuono, G; Hillengass, J; Kyle, R A; Moreau, P; Lahuerta, J J; Landgren, O; Ludwig, H; Larocca, A; Mahindra, A; Cavo, M; Mazumder, A; Mccarthy, P L; Nouel, A; Rajkumar, S V; Reiman, A; Serra, E R; Sezer, O; Terpos, E; Turesson, I; Usmani, S; Weiss, B M; Palumbo, A |
| 41 | Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma | 2017 | Offidani, Massimo; Corvatta, Laura; Bringhen, Sara; Gentili, Silvia; Troia, Rossella; Maracci, Laura; Larocca, Alessandra; Gay, Francesca; Leoni, Pietro; Boccadoro, Mario |
| 42 | Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial | 2019 | Saltarella I.; Morabito F.; Giuliani N.; Terragna C.; Omede P.; Palumbo A.; Bringhen S.; De Paoli L.; Martino E.; Larocca A.; Offidani M.; Patriarca F.; Nozzoli C.; Guglielmelli T.; Benevolo G.; Callea V.; Baldini L.; Grasso M.; Leonardi G.; Rizzo M.; Falcone A.P.; Gottardi D.; Montefusco V.; Musto P.; Petrucci M.T.; Dammacco F.; Boccadoro M.; Vacca A.; Ria R. |
| 43 | Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension | 2019 | Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M. |
| 44 | Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study | 2015 | Musto, Pellegrino; Simeon, Vittorio; Grossi, Alberto; Gay, Francesca; Bringhen, Sara; Larocca, Alessandra; Guariglia, Roberto; Pietrantuono, Giuseppe; Villani, Oreste; D'Arena, Giovanni; Cuomo, Carmela; Musto, Clelia; Morabito, Fortunato; Petrucci, Maria Teresa; Offidani, Massimo; Zamagni, Elena; Tacchetti, Paola; Conticello, Concetta; Milone, Giuseppe; Palumbo, Antonio; Cavo, Michele; Boccadoro, Mario |
| 45 | Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. | 2013 | Larocca A;Montefusco V;Bringhen S;Rossi D;Crippa C;Mina R;Galli M;Marcatti M;La Verde G;Giuliani N;Magarotto V;Guglielmelli T;Rota-Scalabrini D;Omedé P;Santagostino A;Baldi I;Carella AM;Boccadoro M;Corradini P;Palumbo A |
| 46 | Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data. | 2014 | Offidani M;Corvatta L;Caraffa P;Leoni P;Pautasso C;Larocca A;Palumbo A |
| 47 | A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma | 2016 | Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A |
| 48 | Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma | 2018 | Salvini, Marco; Troia, Rossella; Giudice, Davide; Pautasso, Chiara; Boccadoro, Mario; Larocca, Alessandra* |
| 49 | Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) | 2018 | Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika |
| 50 | Optimizing treatment for elderly patients with newly diagnosed multiple myeloma: A personalized approach | 2016 | Larocca, Alessandra; Palumbo, Antonio |
Nome completo:
LAROCCA, Alessandra
Varianti:
A. Larocca
Larocca A
Larocca A
Copyright © 2019